Our results confirm the need to scale up access to viral hepatitis screening in Cameroon to permit early diagnosis of co-infection in newly diagnosed HIV-patients to allow early initiation of the appropriate ART irrespective of CD4 cell counts. This evidence concerns the gene CD4 and viral hepatitis.